Geode Capital Management, LLC Fate Therapeutics Inc Transaction History

Geode Capital Management, LLC

  • $1.26 Trillion
  • Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,226,967 shares of FATE stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,226,967
Previous 2,258,246 1.39%
Holding current value
$2.29 Million
Previous $7.9 Million 53.51%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$1.61 - $3.35 $50,359 - $104,784
-31,279 Reduced 1.39%
2,226,967 $3.67 Million
Q3 2024

Nov 12, 2024
BUY
$3.12 - $5.57 $33,892 - $60,506
10,863 Added 0.48%
2,258,246 $7.9 Million
Q2 2024

Aug 09, 2024
BUY
$3.26 - $7.08 $1.11 Million - $2.42 Million
341,400 Added 17.91%
2,247,383 $7.37 Million
Q1 2024

May 13, 2024
BUY
$3.54 - $8.35 $150,442 - $354,858
42,498 Added 2.28%
1,905,983 $14 Million
Q4 2023

Feb 13, 2024
BUY
$1.65 - $3.94 $145,432 - $347,275
88,141 Added 4.96%
1,863,485 $6.97 Million
Q3 2023

Nov 13, 2023
BUY
$2.02 - $5.04 $61,068 - $152,369
30,232 Added 1.73%
1,775,344 $3.76 Million
Q2 2023

Aug 11, 2023
BUY
$4.76 - $6.59 $630,809 - $873,326
132,523 Added 8.22%
1,745,112 $8.31 Million
Q1 2023

May 15, 2023
BUY
$4.24 - $11.12 $204,783 - $537,073
48,298 Added 3.09%
1,612,589 $9.19 Million
Q4 2022

Feb 13, 2023
BUY
$9.86 - $23.83 $637,064 - $1.54 Million
64,611 Added 4.31%
1,564,291 $15.8 Million
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $715,402 - $1.23 Million
34,002 Added 2.32%
1,499,680 $33.6 Million
Q2 2022

Aug 12, 2022
SELL
$17.78 - $42.39 $152,001 - $362,392
-8,549 Reduced 0.58%
1,465,678 $36.3 Million
Q1 2022

May 13, 2022
BUY
$29.67 - $60.28 $1.43 Million - $2.91 Million
48,259 Added 3.38%
1,474,227 $57.2 Million
Q4 2021

Feb 11, 2022
BUY
$47.84 - $64.34 $1.05 Million - $1.41 Million
21,872 Added 1.56%
1,425,968 $83.4 Million
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $848,153 - $1.37 Million
-14,310 Reduced 1.01%
1,404,096 $83.2 Million
Q2 2021

Aug 13, 2021
BUY
$67.25 - $92.52 $4.65 Million - $6.39 Million
69,094 Added 5.12%
1,418,406 $123 Million
Q1 2021

May 12, 2021
BUY
$72.16 - $117.4 $13.7 Million - $22.3 Million
189,798 Added 16.37%
1,349,312 $111 Million
Q4 2020

Feb 12, 2021
BUY
$38.09 - $100.95 $2.13 Million - $5.66 Million
56,024 Added 5.08%
1,159,514 $105 Million
Q3 2020

Nov 13, 2020
BUY
$30.41 - $40.5 $2.19 Million - $2.92 Million
72,164 Added 7.0%
1,103,490 $44.1 Million
Q2 2020

Aug 13, 2020
BUY
$20.21 - $35.23 $1.67 Million - $2.91 Million
82,538 Added 8.7%
1,031,326 $35.4 Million
Q1 2020

May 14, 2020
BUY
$17.28 - $31.88 $1.24 Million - $2.29 Million
71,953 Added 8.21%
948,788 $21.1 Million
Q4 2019

Feb 13, 2020
BUY
$13.39 - $20.73 $861,003 - $1.33 Million
64,302 Added 7.91%
876,835 $17.2 Million
Q3 2019

Nov 12, 2019
BUY
$15.47 - $22.5 $148,202 - $215,550
9,580 Added 1.19%
812,533 $12.6 Million
Q2 2019

Aug 14, 2019
BUY
$15.61 - $20.44 $188,600 - $246,956
12,082 Added 1.53%
802,953 $16.3 Million
Q1 2019

May 14, 2019
BUY
$13.15 - $18.71 $1.17 Million - $1.66 Million
88,692 Added 12.63%
790,871 $13.9 Million
Q4 2018

Feb 13, 2019
BUY
$11.48 - $16.98 $2.15 Million - $3.17 Million
186,927 Added 36.28%
702,179 $9.01 Million
Q3 2018

Nov 13, 2018
BUY
$8.75 - $16.29 $545,352 - $1.02 Million
62,326 Added 13.76%
515,252 $8.39 Million
Q2 2018

Aug 14, 2018
BUY
$9.16 - $13.48 $442,354 - $650,976
48,292 Added 11.93%
452,926 $5.14 Million
Q1 2018

May 15, 2018
BUY
$6.3 - $13.77 $359,484 - $785,729
57,061 Added 16.42%
404,634 $3.95 Million
Q4 2017

Feb 13, 2018
BUY
$3.94 - $6.64 $177,859 - $299,742
45,142 Added 14.93%
347,573 $2.12 Million
Q3 2017

Nov 14, 2017
BUY
$2.6 - $4.31 $325,907 - $540,254
125,349 Added 70.79%
302,431 $1.2 Million
Q2 2017

Aug 14, 2017
BUY
N/A
177,082
177,082 $573,000

Others Institutions Holding FATE

# of Institutions
167
Shares Held
101M
Call Options Held
41.3K
Put Options Held
15.9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $99.9M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email